Research ArticleArticle
Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States
Karina Raimundo, Amanda M. Farr, Gilwan Kim and George Duna
The Journal of Rheumatology November 2015, jrheum.150479; DOI: https://doi.org/10.3899/jrheum.150479
Karina Raimundo
From Genentech Inc., South San Francisco, California; Truven Health Analytics, Bethesda, Maryland, USA. Funded by Genentech Inc. K. Raimundo and G. Duna are employees of Genentech. A.M. Farr and G. Kim are employees of Truven Health Analytics, which received funding to conduct this analysis from Genentech Inc. K. Raimundo, MS, Health Economist, US Medical Affairs, Genentech Inc.; A.M. Farr, MPH, Research Leader, Truven Health Analytics; G. Kim, PharmD, MS, Sr. Research Analyst, Truven Health Analytics; G. Duna, MD, Rheumatologist with Immunology Medical Affairs, US Medical Affairs, Genentech Inc. Address correspondence to K. Raimundo, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: Raimundo.karina@gene.com. Accepted for publication August 6, 2015.
Amanda M. Farr
From Genentech Inc., South San Francisco, California; Truven Health Analytics, Bethesda, Maryland, USA. Funded by Genentech Inc. K. Raimundo and G. Duna are employees of Genentech. A.M. Farr and G. Kim are employees of Truven Health Analytics, which received funding to conduct this analysis from Genentech Inc. K. Raimundo, MS, Health Economist, US Medical Affairs, Genentech Inc.; A.M. Farr, MPH, Research Leader, Truven Health Analytics; G. Kim, PharmD, MS, Sr. Research Analyst, Truven Health Analytics; G. Duna, MD, Rheumatologist with Immunology Medical Affairs, US Medical Affairs, Genentech Inc. Address correspondence to K. Raimundo, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: Raimundo.karina@gene.com. Accepted for publication August 6, 2015.
Gilwan Kim
From Genentech Inc., South San Francisco, California; Truven Health Analytics, Bethesda, Maryland, USA. Funded by Genentech Inc. K. Raimundo and G. Duna are employees of Genentech. A.M. Farr and G. Kim are employees of Truven Health Analytics, which received funding to conduct this analysis from Genentech Inc. K. Raimundo, MS, Health Economist, US Medical Affairs, Genentech Inc.; A.M. Farr, MPH, Research Leader, Truven Health Analytics; G. Kim, PharmD, MS, Sr. Research Analyst, Truven Health Analytics; G. Duna, MD, Rheumatologist with Immunology Medical Affairs, US Medical Affairs, Genentech Inc. Address correspondence to K. Raimundo, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: Raimundo.karina@gene.com. Accepted for publication August 6, 2015.
George Duna
From Genentech Inc., South San Francisco, California; Truven Health Analytics, Bethesda, Maryland, USA. Funded by Genentech Inc. K. Raimundo and G. Duna are employees of Genentech. A.M. Farr and G. Kim are employees of Truven Health Analytics, which received funding to conduct this analysis from Genentech Inc. K. Raimundo, MS, Health Economist, US Medical Affairs, Genentech Inc.; A.M. Farr, MPH, Research Leader, Truven Health Analytics; G. Kim, PharmD, MS, Sr. Research Analyst, Truven Health Analytics; G. Duna, MD, Rheumatologist with Immunology Medical Affairs, US Medical Affairs, Genentech Inc. Address correspondence to K. Raimundo, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: Raimundo.karina@gene.com. Accepted for publication August 6, 2015.
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States
Karina Raimundo, Amanda M. Farr, Gilwan Kim, George Duna
The Journal of Rheumatology Nov 2015, jrheum.150479; DOI: 10.3899/jrheum.150479